Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00004983
Other study ID # BROWNS (completed)
Secondary ID R01DK048160
Status Completed
Phase N/A
First received March 13, 2000
Last updated February 12, 2010
Start date September 1999
Est. completion date December 2006

Study information

Verified date February 2010
Source National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

The purpose of this ongoing work in Starr County, located on the Texas-Mexico border, is to conduct clinical studies to determine the effectiveness of diabetes self-management programs designed specifically for Mexican Americans. The programs meet national standards for diabetes self-management education. They are provided in community settings with the primary purpose of improving the health of Mexican Americans with diabetes and their family members, who either have diabetes or are at risk for developing diabetes.

The diabetes self-management programs are provided in Spanish and are directed by bilingual Hispanic clinical nurse specialists, dietitians, and community health workers. Key elements of the programs include instruction on nutrition, self-monitoring of blood glucose, exercise, and other diabetes self-management topics, as well as group support to promote behavioral changes.

In the original study (1994-1998), 256 Mexican American adults diagnosed with type 2 diabetes and 256 family members or other support persons were enrolled. For one year, the people with diabetes, along with their family members, attended small group sessions held in churches, community health clinics, adult day care centers, and schools. Information on the effectiveness of the program was collected at 3, 6, and 12 months; and annually thereafter.

Findings of the original study suggested that the program had a positive impact on diabetes metabolic control. Levels of diabetes knowledge and rates of glucose self-monitoring and attendance suggested that a shorter program - one that incorporated critical elements of the previous successful strategy - might result in similar improvements. Thus, the goal of the new study, funded in June 1999, was to shorten the original program and to compare it to the previous successful program in terms of short- and long-term health outcomes.

To identify key components of the previous program, we are exploring differences between subjects who successfully integrated self-care components of the program and who experienced significant improvements in metabolic control and those who were not as successful. The program is being revised and shortened, based on this information. Beginning in April 2000, we will start recruiting participants for the clinical trial of the revised program.


Recruitment information / eligibility

Status Completed
Enrollment 0
Est. completion date December 2006
Est. primary completion date November 2006
Accepts healthy volunteers No
Gender Both
Age group 35 Years to 70 Years
Eligibility Inclusion Criteria:

- Diagnosed with type 2 diabetes ([a] two verifiable FBS test results of 140 mg/dl or above or [b] taking or have taken insulin or hypoglycemic agents for at least one year in the past)

- Willing to participate

- A family member, preferably a spouse or first-degree relative, who agrees to participate

Exclusion Criteria:

- Migrant farm workers (not available for the year-long program)

- Pregnant

- Medical conditions for which changes in diet and exercise levels would be contraindicated

Study Design

Allocation: Non-Randomized, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Behavioral:
diabetes self-management education


Locations

Country Name City State
United States The University of Texas at Austin Austin Texas

Sponsors (1)

Lead Sponsor Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Country where clinical trial is conducted

United States, 

References & Publications (4)

Brown SA, Hanis CL. A community-based, culturally sensitive education and group-support intervention for Mexican Americans with NIDDM: a pilot study of efficacy. Diabetes Educ. 1995 May-Jun;21(3):203-10. — View Citation

Brown SA, Hanis CL. Culturally competent diabetes education for Mexican Americans: the Starr County Study. Diabetes Educ. 1999 Mar-Apr;25(2):226-36. — View Citation

Brown SA, Upchurch SL, Garcia AA, Barton SA, Hanis CL. Symptom-related self-care of Mexican Americans with type 2 diabetes: preliminary findings of the Starr County Diabetes Education Study. Diabetes Educ. 1998 May-Jun;24(3):331-9. — View Citation

Brown SA. Meta-analysis of diabetes patient education research: variations in intervention effects across studies. Res Nurs Health. 1992 Dec;15(6):409-19. — View Citation

See also
  Status Clinical Trial Phase
Completed NCT02801448 - Clinical Trial With Broccoli Sprout Extract to Patients With Type 2 Diabetes Phase 2
Withdrawn NCT01377961 - Effect of Lycopene and Isoflavones on Glucose Metabolism N/A
Completed NCT00754130 - MK-0941 Multiple Dose Study in Japanese Patients With Type 2 Diabetes (MK-0941-011). Phase 1
Completed NCT00006305 - Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes Phase 3
Completed NCT00010751 - Effects of Reiki on Painful Neuropathy and Cardiovascular Risk Factors Phase 2
Completed NCT02299388 - To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study Phase 4
Completed NCT00550329 - Bioequivalence Study Of Glucotrol XL 2.5 Mg Tablets Phase 1
Completed NCT00172536 - Effects of Exercise Training on Left Ventricular Function in Type 2 Diabetic Patients Post Coronary Artery Bypass Graft N/A
Completed NCT00071422 - Safety and Efficacy of INGAP-Peptide in Patients With Type 2 Diabetes Phase 2
Completed NCT00029848 - Obese Patients With Type 2 Diabetes Phase 3
Completed NCT01608724 - The Efficacy and Safety Study in Patients With Type 2 Diabetes Mellitus Phase 4
Completed NCT01694758 - OPtimal Type 2 dIabetes Management Including Benchmarking and Standard Treatment in CEEMEA N/A
Completed NCT00979368 - Safety Study of BMS-816336 in Healthy Male Subjects Phase 1
Completed NCT00791661 - MK-1006 Single Dose Study in Japanese Type 2 Diabetes Patients (MK-1006-005) Phase 1
Active, not recruiting NCT02088658 - Technology Intensified Diabetes Education Study in African Americans N/A
Completed NCT01105429 - Single Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes Phase 1
Completed NCT00701090 - A Study to Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin (0431-803)(COMPLETED) Phase 3
Completed NCT00952991 - The Effects of LAF237 on Gastric Function in Type 2 Diabetes Phase 3
Completed NCT00035984 - Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Phase 3
Completed NCT00044447 - Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to Maximum Dose Metformin & Thiazolidinedione Phase 3